论文部分内容阅读
目的:探讨胸腺五肽联合化学药物治疗复治菌阳肺结核的临床疗效,并为更好的治疗复治菌阳肺结核提供一定的依据。方法:我院收治的150例复治菌阳肺结核患者,随机的分成实验组75例,对照组75例。对照组进行化学药物的治疗,实验组在化学药物治疗的基础上加入胸腺五肽治疗,治疗期间随访痰菌阴转、病灶吸收情况,治疗后1年对两组患者治疗效果进行统计分析。结果:治疗2、4、6、8个月时实验组患者痰菌转阴率均明显优于对照组;实验组患者治疗显效优于对照组;实验组组患者治疗无效及患者发生不艮反应的结果均优于对照组。结论:对复治菌阳肺结核实施胸腺五肽联合化学药物进行治疗是一种安全而有效的治疗方法。
Objective: To investigate the clinical efficacy of thymopentin combined with chemical drugs in the treatment of retreatment of positive pulmonary tuberculosis, and to provide a basis for better treatment of retreatment of positive pulmonary tuberculosis. Methods: 150 cases of convalescent bacilli in our hospital were randomly divided into experimental group (75 cases) and control group (75 cases). The control group was treated with chemotherapeutic drugs. The experimental group was treated with thymopentin on the basis of chemical therapy. During the treatment, sputum negative conversion and lesions absorption were followed up, and the treatment effects of the two groups were statistically analyzed one year after treatment. Results: The sputum bacterium negative rate of the experimental group was obviously better than that of the control group at the 2nd, 4th, 6th and 8th month of treatment. The curative effect of the experimental group was better than that of the control group. The treatment group was ineffective and the patients did not respond The results are better than the control group. Conclusion: It is a safe and effective treatment for retreatment of positive pulmonary tuberculosis with thymopentin combined with chemical drugs.